Epigenomics AG and NextPharma Sign Global Manufacturing Deal for Colorectal Cancer Blood Test
08-Oct-2010 -
Epigenomics AG and NextPharma Technologies announced that the companies have signed a global manufacturing contract for Epigenomics' Epi proColon product. Epi proColon, currently marketed in Europe, is the world's first in-vitro diagnostic test for the detection of colorectal cancer in a simple ...
colorectal cancer
diagnostic tests
food
+1